Divalproex Extended Release and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Divalproex Extended Release and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: divalproex sodium
Brand name: Depakote ER, Depakote Sprinkles, Depakote, Depakene, Depacon
Synonyms: Divalproex sodium, Divalproex
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Divalproex Extended Release-Insulin degludec
- Divalproex Extended Release-Insulin Degludec (U-100) Prefilled Pens
- Divalproex Extended Release-Insulin Degludec (U-100) Vials
- Divalproex Extended Release-Insulin Degludec (U-200) Prefilled Pens
- Divalproex Extended Release-Insulin degludec and liraglutide
- Divalproex Extended Release-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Divalproex Long-Acting Tablets
- Insulin aspart, recombinant Subcutaneous-Divalproex sodium
- Insulin aspart, recombinant Subcutaneous-Divalproex Sprinkle
- Insulin aspart, recombinant Subcutaneous-Divalproex Sprinkle Capsules
- Insulin aspart, recombinant Subcutaneous-Divigel
- Insulin aspart, recombinant Subcutaneous-Divigel 0.75 mg/packet for use on skin